- Home
- CARG vs ZLAB Comparison
CARG vs ZLAB Comparison
Compare CARG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARG
- ZLAB
- Stock Information
- Founded
- CARG 2005
- ZLAB 2013
- Country
- CARG United States
- ZLAB China
- Employees
- CARG N/A
- ZLAB N/A
- Industry
- CARG EDP Services
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- CARG Technology
- ZLAB Health Care
- Exchange
- CARG Nasdaq
- ZLAB Nasdaq
- Market Cap
- CARG 3.2B
- ZLAB 3.2B
- IPO Year
- CARG 2017
- ZLAB 2017
- Fundamental
- Price
- CARG $35.64
- ZLAB $21.77
- Analyst Decision
- CARG Buy
- ZLAB Buy
- Analyst Count
- CARG 10
- ZLAB 6
- Target Price
- CARG $39.60
- ZLAB $57.22
- AVG Volume (30 Days)
- CARG 939.0K
- ZLAB 937.6K
- Earning Date
- CARG 11-06-2025
- ZLAB 11-06-2025
- Dividend Yield
- CARG N/A
- ZLAB N/A
- EPS Growth
- CARG N/A
- ZLAB N/A
- EPS
- CARG 1.46
- ZLAB N/A
- Revenue
- CARG $926,425,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- CARG $6.25
- ZLAB $40.71
- Revenue Next Year
- CARG $5.66
- ZLAB $50.42
- P/E Ratio
- CARG $24.38
- ZLAB N/A
- Revenue Growth
- CARG 4.21
- ZLAB 24.14
- 52 Week Low
- CARG $24.65
- ZLAB $21.25
- 52 Week High
- CARG $41.33
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- CARG 52.67
- ZLAB 23.43
- Support Level
- CARG $32.46
- ZLAB $21.59
- Resistance Level
- CARG $36.33
- ZLAB $22.28
- Average True Range (ATR)
- CARG 1.39
- ZLAB 0.86
- MACD
- CARG 0.17
- ZLAB -0.20
- Stochastic Oscillator
- CARG 81.78
- ZLAB 7.69
About CARG CarGurus Inc.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.